Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-13 Purchase | 2022-12-15 7:53 pm | Humacyte Inc. | HUMA | Scheessele William John Chief Commercial Officer | 5,000 | $3.09 | $15,450 | 15,525 (Direct) | View |
| 2022-05-24 Purchase | 2022-05-25 11:46 am | Humacyte Inc. | HUMA | Scheessele William John Chief Commercial Officer | 10,525 | $4.72 | $49,678 | 10,525 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-08 Option Award | 2023-12-12 4:10 pm | N/A 2033-12-08 | Humacyte Inc. | HUMA | Scheessele William John Chief Commercial Officer | 276,000 | $0 | 276,000 (Direct) | View |
| 2022-12-08 Option Award | 2022-12-12 4:15 pm | N/A 2032-12-08 | Humacyte Inc. | HUMA | Scheessele William John Chief Commercial Officer | 136,000 | $0 | 136,000 (Direct) | View |
| 2021-10-13 Option Award | 2021-10-15 3:51 pm | N/A 2031-10-13 | Humacyte Inc. | HUMA | Scheessele William John Chief Commercial Officer | 157,558 | $0 | 157,558 (Direct) | View |